Skip to main content
. Author manuscript; available in PMC: 2012 Jul 23.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008305. doi: 10.1002/14651858.CD008305.pub2

Appendix 15. Sensitivity analysis on hypercholesterolemic patients with or without hypertriglyceridemia.

Outcome Sensitivity analysis on selective reporting Result
1.1.4 TC Exclude studies recruiting hypercholesteraemic patients
with hypertriglyceridemia (Deng 2006; Hua 2008; Li 2006)
and studies recruiting hypercholesteraemic patients and
hypercholesteraemic patients with hypertriglyceridemia
(Li 2005; Qi 2004)		 MD 0.25 (95% CI −0.45 to 0.94)
I2 = 93%
1.1.3 TC Exclude study recruiting hypercholesteraemic patients
and hypercholesteraemic patients with hypertriglyc-
eridemia (Li 2005)		 MD 0.04 (95% CI −0.22 to 0.30)
I2 = 50%
1.1.7 TC Exclude study recruiting hypercholesteraemic patients
with hypertriglyceridemia (Zhang 2005)		 MD 0.11 (95% CI −0.39 to 0.61)
I2 = not applicable
1.2.4 TG Exclude studies recruiting hypercholesteraemic patients
with hypertriglyceridemia (Deng 2006; Hua 2008; Li 2006)
and studies recruiting hypercholesteraemic patients and
hypercholesteraemic patients with hypertriglyceridemia
(Li 2005; Qi 2004)		 MD 0.04 (95% CI −0.29 to 0.38)
I2 = 57%
1.2.3 TG Exclude study recruiting hypercholesteraemic patients
and hypercholesteraemic patients with hypertriglyc-
eridemia (Li 2005)		 MD −0.13 (95% CI −0.25 to −0.00)
I2 = 29%
1.3.4 HDL-C Exclude recruiting hypercholesteraemic patients patients
with hypertriglyceridemia (Deng 2006; Hua 2008)
and studies recruiting hypercholesteraemic patients and
hypercholesteraemic patients with hypertriglyceridemia
(Li 2005; Qi 2004)		 MD −0.04 (95% CI −0.24 to 0.16)
I2 = 93%
1.3.3 HDL-C Exclude study recruiting hypercholesteraemic patients
and hypercholesteraemic patients with hypertriglyc-
eridemia (Li 2005)		 MD −0.05 (95% CI −0.12 to 0.03)
I2 = 4%
1.4.4 LDL-C Exclude studies recruiting hypercholesteraemic patients
with hypertriglyceridemia (Deng 2006; Hua 2008; Li 2006)
and studies recruiting hypercholesteraemic patients and
hypercholesterolemia patients with hypertriglyceridemia
(Li 2005; Qi 2004)		 MD 0.29 (95% CI −0.35 to 0.93)
I2 = 91%
1.4.3 LDL-C Exclude study recruiting hypercholesteraemic patients
and hypercholesteraemic patients with hypertriglyc-
eridemia (Li 2005)		 MD −0.05 (95% CI −0.30 to 0.20)
I2 = 53%
1.4.7 LDL-C Exclude study recruiting hypercholesteraemic patients
with hypertriglyceridemia (Zhang 2005)		 MD 0.13 (95% CI −0.34 to 0.60)
I2 = not applicabe